206 related articles for article (PubMed ID: 12423690)
1. Antiviral prophylaxis and treatment (excluding HIV therapy).
Waugh SM; Pillay D; Carrington D; Carman WF
J Clin Virol; 2002 Dec; 25(3):241-66. PubMed ID: 12423690
[No Abstract] [Full Text] [Related]
2. Drugs for non-HIV viral infections.
Treat Guidel Med Lett; 2005 Apr; 3(32):23-32. PubMed ID: 15767977
[No Abstract] [Full Text] [Related]
3. Prevention and treatment of viral infections in stem cell transplant recipients.
Ljungman P
Br J Haematol; 2002 Jul; 118(1):44-57. PubMed ID: 12100127
[No Abstract] [Full Text] [Related]
4. Treatment of opportunistic viral infections.
Crumpacker CS
AIDS; 1988; 2 Suppl 1():S191-3. PubMed ID: 2852503
[No Abstract] [Full Text] [Related]
5. [Antiviral chemotherapy].
Eggers HJ
Monatsschr Kinderheilkd; 1986 Mar; 134(3):122-9. PubMed ID: 3010086
[TBL] [Abstract][Full Text] [Related]
6. Antiviral therapy. Varicella-zoster virus infections, herpes labialis and mucocutaneous herpes, and cytomegalovirus infections.
Nicholson KG
Lancet; 1984 Sep; 2(8404):677-82. PubMed ID: 6147701
[No Abstract] [Full Text] [Related]
7. Antiviral therapy. New drugs and their uses.
Bean B
Postgrad Med; 1986 Jul; 80(1):109-10, 113-4, 117-20. PubMed ID: 2425347
[No Abstract] [Full Text] [Related]
8. [Antiviral therapy of immunocompromised patients].
Eggers HJ
Immun Infekt; 1984 Aug; 12(4):187-91. PubMed ID: 6090308
[TBL] [Abstract][Full Text] [Related]
9. [New developments and prospects of antiviral chemotherapy].
Vogt M; Bernasconi E; Lüthy R
Internist (Berl); 1992 Sep; 33(9):597-601. PubMed ID: 1328109
[No Abstract] [Full Text] [Related]
10. Guidelines for laboratory monitoring of treatment of persistent virus infections.
Pillay D; Emery VC; Mutimer D; Ogilvie MM; Carman W; Mutton K; Wreghitt T; Westmoreland D; Breuer J; Zuckerman M;
J Clin Virol; 2002 Jul; 25(1):73-92. PubMed ID: 12126724
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of varicella zoster and herpes simplex virus-induced diseases. 2: References for implementing and indications for virustatic therapy].
Mahler V; Schuler G
Hautarzt; 2001 Jun; 52(6):554-73. PubMed ID: 11428090
[No Abstract] [Full Text] [Related]
12. [Therapy of varicella zoster and herpes simplex virus-induced diseases. 1: Virustatic agents].
Mahler V; Schuler G
Hautarzt; 2001 May; 52(5):464-71; quiz 471. PubMed ID: 11405170
[No Abstract] [Full Text] [Related]
13. Antiviral therapies.
Hallenberger S
J Clin Virol; 2004 Apr; 30 Suppl 1():S23-5. PubMed ID: 15062765
[No Abstract] [Full Text] [Related]
14. Antiviral chemotherapy and chemoprophylaxis.
Dolin R
Science; 1985 Mar; 227(4692):1296-303. PubMed ID: 2983421
[TBL] [Abstract][Full Text] [Related]
15. Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
Brown TJ; McCrary M; Tyring SK
J Am Acad Dermatol; 2002 Oct; 47(4):581-99. PubMed ID: 12271305
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir treatment of herpes simplex virus infections in immunocompromised humans. An overview.
Alford CA
Am J Med; 1982 Jul; 73(1A):225-8. PubMed ID: 6285714
[TBL] [Abstract][Full Text] [Related]
17. Antivirals against DNA viruses (hepatitis B and the herpes viruses).
Hewlett G; Hallenberger S; Rübsamen-Waigmann H
Curr Opin Pharmacol; 2004 Oct; 4(5):453-64. PubMed ID: 15351349
[TBL] [Abstract][Full Text] [Related]
18. Advances in antiviral therapy: acyclovir.
Chadwick EG; Shulman ST
Pediatr Dermatol; 1984 Jul; 2(1):64-70. PubMed ID: 6095238
[TBL] [Abstract][Full Text] [Related]
19. Resistance in viruses other than HIV.
Griffiths PD
Int J Infect Dis; 2002 Mar; 6 Suppl 1():S32-7. PubMed ID: 12044287
[TBL] [Abstract][Full Text] [Related]
20. The present and future for acyclovir.
Brigden D; Keeney RE; King DH
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():195-9. PubMed ID: 6313599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
